Skip to main content

Immunomodulatory Capacity of Drugs Evaluated in a Mouse Model of Klebsiella pneumoniae Infection

  • Conference paper
Immunotherapeutic Prospects of Infectious Diseases

Abstract

Two types of information are needed for an objective assessment of immunomodulatory (IM) activities of a drug: data on functional alterations of all basic elements of the immune system caused by the drug (as revealed by a panel of in vitro/ex vivo tests), and on its overall impact on resistance. The latter purpose is served by experimental models of infections or transplantable tumors.In this paper we present results of a comparative study evaluating immunostimulatory potency of three microbial and two synthetic preparations in a mouse model of an acute bacterial infection.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  • Cluff CW, Ziegler HK (1987) An early response to lipopolysaccharide is the elicitation of macrophages specialized for antigen degradation with negative regulatory effects on the induction of specific immune responses. Infect Immun 55: 1346–1357

    PubMed  CAS  Google Scholar 

  • Franék J, Malina J, Libich J (1986) Local antibacterial immunity in the lower airways: limits of its effectiveness. In:Ryc M, Franék J (eds) Bacteria and the Host. Avicenum, Prague, p 333

    Google Scholar 

  • Iizawa Y, Nishi T, Kondo M, Imada A (1988) Experimental chronic pulmonary infection in mice caused by Klebsiella pneumoniae. Microbiol Immunol 32: 895–906

    PubMed  CAS  Google Scholar 

  • Malina J, Franük J (to be published) Informative value of a mouse model of Klebsiella pneumoniae infection used as a host-resistance assay. Folia Microbiol

    Google Scholar 

  • Nassif X, Fournier JM, Arondel J, Sansonetti PJ (1989) Mucoid phenotype of Klebsiella pneumoniae is a plasmid-encoded virulence factor. Infect Immun 57: 546–552

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Franěk, J., Malina, J. (1990). Immunomodulatory Capacity of Drugs Evaluated in a Mouse Model of Klebsiella pneumoniae Infection. In: Masihi, K.N., Lange, W. (eds) Immunotherapeutic Prospects of Infectious Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76120-1_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-76120-1_6

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-76122-5

  • Online ISBN: 978-3-642-76120-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics